Filing Flows › Bolt Biotherapeutics (BOLT) › Q2 2026 › vs Q1 2026
Bolt Biotherapeutics (BOLT) Q2 2026 vs Q1 2026 (quarter over quarter)
Bolt Biotherapeutics's revenue fell $21K (-81%) from $26K in Q1 2026 to $5K in Q2 2026.
Bolt Biotherapeutics, Q2 2026: revenue $5K (-100% year over year), net loss $7.7M, operating cash flow −$6.5M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $5K | $26K | −$21K | -81% |
| Other income, net | $654K | $357K | $297K | +83% |
| Net loss | $7.7M | $7.2M | $476K | +7% |
| Costs & expenses | $8.4M | $7.6M | $752K | +10% |
| Operating costs | $8.4M | $7.6M | $752K | +10% |
| Research & development | $5.1M | $4.8M | $320K | +7% |
| General & admin | $2.4M | $2.8M | −$376K | -13% |
| Operating cash sources | $7.7M | $7.2M | $476K | +7% |
| Depreciation & amortization | $171K | $203K | −$32K | -16% |
| Share-based compensation | $552K | $545K | $7K | +1% |
| Working capital & other | $457K | −$1.5M | $2.0M | — |
| Cash used in operations | $6.5M | $8.0M | −$1.5M | -18% |
| Net loss absorbed | $7.7M | $7.2M | $476K | +7% |
Questions
How much did Bolt Biotherapeutics's revenue grow quarter over quarter in Q2 2026?
Bolt Biotherapeutics's revenue fell $21K (-81%) from $26K in Q1 2026 to $5K in Q2 2026.